FDA Drug Application (022200) for BYDUREON by ASTRAZENECA AB

Back to FDA Applications sponsored by ASTRAZENECA AB

Application Number022200
Product Number001
FormFOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS
Dosage2MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBYDUREON
Active IngredientEXENATIDE SYNTHETIC



Back to FDA Applications sponsored by ASTRAZENECA AB

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.